Company: PCRX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001396814-25-000061
Chunk: 65

Company: Pacira BioSciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1
Chunk 65
---
retion(2,675)Balance at March 31, 2025$17,566 Available-for-Sale InvestmentsShort-term investments consist of asset-backed securities collateralized by credit card receivables, investment grade commercial paper and corporate, federal agency, government and Yankee bonds with maturities greater than three months, but less than one year. Net unrealized gains and losses (excluding credit losses, if any) from the Company’s short-term investments are reported in other comprehensive income. At March 31, 2025 and December 31, 2024, all of the Company’s short-term and noncurrent investments are classified as available-for-sale investments and are determined to be Level 2 instruments, with the exception of U.S. government bonds, which are measured at fair value using standard industry models with observable inputs. The fair value of the commercial paper is measured based on a standard industry model that uses the three-month U.S. Treasury bill rate as an observable input. The fair value of the asset-backed securities and corporate bonds is principally measured or corroborated by trade data for identical issues in which related trading activity is not sufficiently frequent to be considered a Level 1 input or that of comparable securities. The fair value of U.S. government bonds is based on level 1 trading activity. At the time of purchase, all available-for-sale investments had an “A” or better rating by Standard & Poor’s. 

Pacira BioSciences, Inc.  |  Q1 2025 Form 10-Q  |  Page 23

The following summarizes the Company’s short-term available-for-sale investments at March 31, 2025 and December 31, 2024 (in thousands): March 31, 2025 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$10,691 $10 $(2)$10,699 Commercial paper154,105 42 (30)154,117 Corporate bonds40,179 11 (6)40,184 Yankee bond5,006 10 — 5,016           Total$209,981 $73 $(38)$210,016 December 31, 2024 InvestmentsCostGrossUnrealizedGainsGrossUnrealizedLossesFair Value(Level 2)Current:Asset-backed securities$21,626 $43 $— $21